HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yoo-Duk Choi Selected Research

Glycochenodeoxycholic Acid (Glycochenodeoxycholate)

1/2022Primary bile acid activates Egr‑1 expression through the MAPK signaling pathway in gastric cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yoo-Duk Choi Research Topics

Disease

21Neoplasms (Cancer)
01/2023 - 08/2011
13Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2024 - 08/2012
8Lung Neoplasms (Lung Cancer)
10/2021 - 08/2016
6Neoplasm Metastasis (Metastasis)
01/2023 - 08/2012
5Adenocarcinoma
01/2023 - 01/2011
5Stomach Neoplasms (Stomach Cancer)
01/2022 - 12/2009
2Marginal Zone B-Cell Lymphoma (MALT Lymphoma)
01/2023 - 01/2014
2Lupus Nephritis
09/2021 - 02/2018
2Chronic Renal Insufficiency
09/2021 - 05/2019
2Inflammation (Inflammations)
01/2021 - 09/2014
2Fibrosis (Cirrhosis)
02/2018 - 04/2012
2Lymphoma (Lymphomas)
01/2014 - 03/2012
2Rectal Neoplasms (Rectal Cancer)
08/2012 - 05/2012
2Colorectal Neoplasms (Colorectal Cancer)
08/2011 - 12/2009
1Myocarditis (Carditis)
08/2022
1COVID-19
08/2022
1Metaplasia
01/2022
1Liver Failure
01/2022
1Neuroendocrine Carcinoma
01/2022
1Carcinogenesis
01/2022
1Atrophic Gastritis
01/2022
1Cardiac Arrhythmias (Arrythmia)
01/2022
1Atrial Fibrillation
01/2022
1Adenocarcinoma of Lung
10/2021
1Paraparesis
10/2021
1Air Embolism (Gas Embolism)
11/2020
1Vitiligo
08/2020
1Melanoma (Melanoma, Malignant)
08/2020
1Pancreatic Neoplasms (Pancreatic Cancer)
05/2020
1Sarcoidosis (Schaumann Disease)
03/2020
1Diaschisis
01/2020
1Systemic Lupus Erythematosus (Libman-Sacks Disease)
05/2019
1Pneumonia (Pneumonitis)
10/2018
1Lymphadenopathy
10/2018
1Sclerosis
02/2018
1Atrophy
02/2018
1Starvation
01/2018
1Osteosarcoma (Osteogenic Sarcoma)
01/2017
1Meckel syndrome type 3
01/2017
1COACH syndrome
01/2017
1Congenital Hepatic Fibrosis
01/2017
1Cerebellar Ataxia (Dysmetria)
01/2017

Drug/Important Bio-Agent (IBA)

7ErbB Receptors (EGF Receptor)IBA
01/2023 - 09/2014
4Proteins (Proteins, Gene)FDA Link
01/2017 - 04/2012
3DNA (Deoxyribonucleic Acid)IBA
01/2023 - 10/2015
3Anaplastic Lymphoma KinaseIBA
01/2023 - 08/2019
3Cisplatin (Platino)FDA LinkGeneric
01/2017 - 08/2012
3AntigensIBA
01/2014 - 11/2011
2Circulating Tumor DNAIBA
01/2021 - 04/2019
2osimertinibIBA
01/2021 - 04/2019
2Glutathione PeroxidaseIBA
11/2020 - 08/2016
2pembrolizumabIBA
08/2020 - 01/2020
2Adrenal Cortex Hormones (Corticosteroids)IBA
08/2020 - 03/2020
2Immune Checkpoint InhibitorsIBA
08/2020 - 01/2020
2Glial Cell Line-Derived Neurotrophic Factor (GDNF)IBA
05/2020 - 01/2017
2LigandsIBA
05/2020 - 01/2020
2Pemetrexed (MTA)FDA Link
01/2019 - 01/2017
2Phosphotransferases (Kinase)IBA
01/2018 - 07/2013
2Docetaxel (Taxotere)FDA Link
01/2017 - 08/2012
1selpercatinibIBA
01/2023
1NVX-CoV2373 adjuvated lipid nanoparticleIBA
08/2022
1VaccinesIBA
08/2022
1Amiodarone (Amiodarona)FDA LinkGeneric
01/2022
1Cholic AcidIBA
01/2022
1Glycochenodeoxycholic Acid (Glycochenodeoxycholate)IBA
01/2022
1Clopidogrel (Plavix)FDA Link
01/2022
1PlatinumIBA
01/2022
1Transaminases (Aminotransferases)IBA
01/2022
1Bile Acids and Salts (Bile Acids)IBA
01/2022
1lorlatinibIBA
10/2021
1GadoliniumIBA
10/2021
1Uric Acid (Urate)IBA
09/2021
1STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA
01/2021
1Biomarkers (Surrogate Marker)IBA
11/2020
1Growth Factor ReceptorsIBA
11/2020
1Small Interfering RNA (siRNA)IBA
05/2020
1Glucose (Dextrose)FDA LinkGeneric
01/2020
1NivolumabIBA
01/2020
1AntibodiesIBA
05/2019
1CreatinineIBA
05/2019
1Thymidylate SynthaseIBA
01/2019
1Surface-Active Agents (Surfactants)IBA
10/2018
1Protein CIBA
10/2018
1Hydroxychloroquine (Plaquenil)FDA LinkGeneric
02/2018
1Immunosuppressive Agents (Immunosuppressants)IBA
02/2018
1Erlotinib Hydrochloride (CP 358,774)FDA Link
01/2018
1Cyclin B1IBA
01/2018
1Oxidants (Oxidizing Agents)IBA
01/2018
1SilverIBA
01/2018
1Phosphoric Monoester Hydrolases (Phosphatases)IBA
01/2018
1Guanosine Triphosphate (GTP)IBA
01/2017
1gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA
01/2017

Therapy/Procedure

7Therapeutics
10/2021 - 01/2013
5Radiotherapy
01/2023 - 05/2012
5Drug Therapy (Chemotherapy)
01/2022 - 05/2012
3Chemoradiotherapy
01/2024 - 11/2014
1Animal Assisted Therapy
01/2023
1Liver Transplantation
01/2022
1Excimer Lasers
08/2020
1Palliative Care (Palliative Therapy)
06/2020